Clinical Trial Update: Stereotactic Radiosurgery Combination With Anlotinib for Limited Brain Metastases With Perilesional Edema in NSCLC [Phase 2]

View source ↗

Summary

Phase 2 trial update investigating stereotactic radiosurgery with anlotinib for limited brain metastases in NSCLC with perilesional edema.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Brain Metastases
• Non-small Cell Lung Cancer

Drugs mentioned

• Anlotinib (anlotinib)

Snippet

Sponsor: Peking University Third Hospital | Conditions: Stereotactic Body Radiation Therapy | Phase 2 | Status: UNKNOWN